DexCom Inc
Close on Nov 20, 2026Market cap $29.58BP/E 31.2Yield –
DexCom Global Active CGM Customer Base by Year
Global Active CGM Customer Base — Reported / Low Bound (M)
DexCom Global Active CGM Customer Base: 3.50M in FY2025, up 25.0% from a year earlier.
Where the FY2025 figure comes from
“2025 closed with approximately 3.5 million users globally (excluding Stelo).”
Source: DexCom 2025 Annual Report & Shareholder Letter ↗
Year-end global active users of DexCom prescription CGM systems (G-Series / Dexcom ONE+, excluding Stelo OTC biosensors). FY2024 was reported as a range of approximately 2.8–2.9 million users.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Global Active CGM Customer Base — Reported / Low Bound (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.50 | +25.0% | DexCom 2025 Annual Report & Shareholder Letter ↗ |
| FY2024 | Dec 31, 2024 | 2.80 | +21.7% | DexCom 2024 Annual Report & Shareholder Letter ↗ |
| FY2023 | Dec 31, 2023 | 2.30 | +35.3% | DexCom 2023 Annual Report & Shareholder Letter ↗ |
| FY2022 | Dec 31, 2022 | 1.70 | +36.0% | DexCom 2022 Annual Report & Shareholder Letter ↗ |
| FY2021 | Dec 31, 2021 | 1.25 | +38.9% | DexCom 2021 Annual Report & Shareholder Letter ↗ |
| FY2020 | Dec 31, 2020 | 0.90 | +38.5% | DexCom 2026 Investor Day Presentation (May 2026) ↗ |
| FY2019 | Dec 31, 2019 | 0.65 | – | DexCom 2019 Annual Report & Shareholder Letter ↗ |
Breakdown
What makes up global Active CGM Customer Base
Cite this data
StockData. (2026). DexCom Global Active CGM Customer Base (M), annual FY2019–FY2025 [Data set]. Compiled from DexCom SEC filings and investor materials. https://stockdatahq.com/stocks/dxcm/kpis/cust-active-low
See every metric in the DexCom KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?